Point-of-care Testing (POCT) for Tumor Marker Market was valued at USD 2.4 Billion in 2022 and is projected to reach USD 4.6 Billion by 2030, growing at a CAGR of 8.7% from 2024 to 2030.
Point-of-care testing (POCT) for tumor markers has witnessed substantial growth between 2018 and 2022, driven by advancements in healthcare technologies and an increasing demand for quick, accurate, and non-invasive diagnostic tools. Tumor markers, which are substances found in blood, urine, or tissues that can be indicative of cancer, have become integral in early cancer detection. The market for POCT solutions targeting these markers experienced significant growth as healthcare systems sought to reduce diagnostic time and costs. These innovations also paved the way for more personalized medicine, where patients can be monitored for tumor markers without the need for lengthy hospital visits.
During 2018 to 2022, technological improvements in biosensors and microfluidics enabled the development of more compact, portable, and efficient testing devices. The widespread adoption of smartphones and handheld devices also played a role in the evolution of POCT, allowing patients to test tumor markers at home or in remote areas, far from conventional diagnostic centers. Furthermore, growing awareness about cancer's rising incidence fueled demand for these testing solutions, particularly in emerging markets where access to specialized healthcare is limited.
Looking ahead to 2023-2033, the demand for POCT in tumor marker testing is projected to increase even further, driven by a variety of factors. A growing focus on cancer prevention and early detection, coupled with advances in artificial intelligence (AI) and machine learning, is expected to revolutionize how these tests are performed. New biomarker discoveries, especially for hard-to-diagnose cancers, will expand the scope of POCT applications, making these tests more accurate and applicable across various types of tumors.
The rise of telemedicine and the increasing need for decentralized healthcare services also provide strong catalysts for growth in this sector. For instance, patients in rural or underserved areas can benefit from immediate access to tumor marker testing without the necessity of traveling to urban medical centers. Additionally, regulatory changes and increased reimbursement for POCT solutions are expected to further stimulate market growth, encouraging manufacturers to develop affordable and innovative products.
Get an In-Depth Research Analysis of the Global Point-of-care Testing (POCT) for Tumor Marker Market Size And Forecast [2025-2032]
Roche
Abbott
BioMerieux
Wondfo Biotech
Yuwell
Getein Biotech
Beijing Wantai BioPharm
Assure Tech
Randox
Orient Gene
Hangzhou Biotest
Shenzhen YHLO
Qingdao Hightop Biotech Co.
Ltd.
Getein Biotech
Inc.
Wuhan Easy Diagnosis Biomedicine Co.
ltd.
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Point-of-care Testing (POCT) for Tumor Marker Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Point-of-care Testing (POCT) for Tumor Marker Market
Hospital
lndependent Testing Organization
Based on Types the Market is categorized into Below types that held the largest Point-of-care Testing (POCT) for Tumor Marker market share In 2023.
Based on Immunochromatography
Based on Chemiluminescence Technology
Based on Biosensor
Others
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Point-of-care Testing (POCT) for Tumor Marker Market Research Analysis
1. Introduction of the Global Point-of-care Testing (POCT) for Tumor Marker Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Point-of-care Testing (POCT) for Tumor Marker Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Point-of-care Testing (POCT) for Tumor Marker Market, By Type
6. Global Point-of-care Testing (POCT) for Tumor Marker Market, By Application
7. Global Point-of-care Testing (POCT) for Tumor Marker Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Point-of-care Testing (POCT) for Tumor Marker Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/